Skip to main content
ERC
News
Participate
Patients
Doctors
Investors
Products
Gliovac/ERC1671
Media
News
Publications
About
Executive Management
Executive board
Scientific board
Milestone achievements
Contact
News
Publications
01
Apr
2020
In Q2 2020 after enrolling about 40 patients in the Phase II clinical trial, ERC will submit its request for commercialization in the USA
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our
cookies information
for more details.
Close